The AIM with Immunotherapy Initiative – Home › Forums › Immunotherapy › Side-effect management › BRAF/MEK inhibitors and statins › Reply To: BRAF/MEK inhibitors and statins
December 14, 2017 at 4:47 pm #4560
Expert NurseVirginia Seery
Thank you Kathleen and Lisa for your feedback.
Kathleen, we are going to start maintenance dosing with infliximab which is a great suggestion. Lisa, I had not thought about approaching the company for assistance. I will look into that. We have sent stool for C diff, shigella, salmonella and camplyobacter all of which were negative. Interestingly, she is now being treated for serratia bacteremia with cipro so it will interesting to see if that helps.